Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
369 |
issn |
1179-6901 1174-5886 |
issueIdentifier |
6 |
pageRange |
368-369 |
publicationName |
Drugs in R & D |
startingPage |
368 |
bibliographicCitation |
Testosterone Undecanoate-Schering AG. Drugs R D. 2004;5(6):368–9. doi: 10.2165/00126839-200405060-00012. PMID: 15563244. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09674209e11499b5f89e624a13e843a6 |
date |
200411 |
identifier |
https://doi.org/10.2165/00126839-200405060-00012 https://pubmed.ncbi.nlm.nih.gov/15563244 |
isPartOf |
https://portal.issn.org/resource/ISSN/1179-6901 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21561 https://portal.issn.org/resource/ISSN/1174-5886 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Testosterone Undecanoate — Schering AG |
discusses |
http://id.nlm.nih.gov/mesh/M0056567 http://id.nlm.nih.gov/mesh/M0021196 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8122 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65157 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738 |